| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Comparison of Outcomes for Cord Blood Transplantation and Unrelated Bone Marrow Transplantation in Adult Aplastic Anemia
|
Kuwatsuka, Yachiyo
|
|
2016
|
22 |
10 |
p. 1836-1843
8 p.
|
artikel
|
| 2 |
Administrative Claims Data for Economic Analyses in Hematopoietic Cell Transplantation: Challenges and Opportunities
|
Preussler, Jaime M.
|
|
2016
|
22 |
10 |
p. 1738-1746
9 p.
|
artikel
|
| 3 |
A Novel Reduced-Toxicity Myeloablative Conditioning Regimen Using Full-Dose Busulfan, Fludarabine, and Melphalan for Single Cord Blood Transplantation Provides Durable Engraftment and Remission in Nonremission Myeloid Malignancies
|
Yamamoto, Hisashi
|
|
2016
|
22 |
10 |
p. 1844-1850
7 p.
|
artikel
|
| 4 |
A Pharmacokinetic and Pharmacodynamic Study of Maraviroc as Acute Graft-versus-Host Disease Prophylaxis in Pediatric Allogeneic Stem Cell Transplant Recipients with Nonmalignant Diagnoses
|
Khandelwal, Pooja
|
|
2016
|
22 |
10 |
p. 1829-1835
7 p.
|
artikel
|
| 5 |
Cytokine Release Syndrome after Haploidentical Stem Cell Transplantation
|
Teachey, David T.
|
|
2016
|
22 |
10 |
p. 1736-1737
2 p.
|
artikel
|
| 6 |
Cytomegalovirus Status and the Outcome of T Cell–Replete Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation
|
Verduyn Lunel, Frans M.
|
|
2016
|
22 |
10 |
p. 1883-1887
5 p.
|
artikel
|
| 7 |
Dasatinib-Induced Colitis after Allogeneic Stem Cell Transplantation for Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
|
Aldoss, Ibrahim
|
|
2016
|
22 |
10 |
p. 1900-1903
4 p.
|
artikel
|
| 8 |
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: Final Results From the International Compassionate-Use Program
|
Corbacioglu, Selim
|
|
2016
|
22 |
10 |
p. 1874-1882
9 p.
|
artikel
|
| 9 |
Early Lung Computed Tomography Scan after Allogeneic Hematopoietic Stem Cell Transplantation
|
Olchowy, Cyprian
|
|
2016
|
22 |
10 |
p. 1908-1909
2 p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
2016
|
22 |
10 |
p. A2-
1 p.
|
artikel
|
| 11 |
Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma
|
Kekre, Natasha
|
|
2016
|
22 |
10 |
p. 1808-1815
8 p.
|
artikel
|
| 12 |
Hematopoietic, Mesenchymal, and Immune Cells Are More Enhanced in Bone Marrow than in Peripheral Blood from Granulocyte Colony-Stimulating Factor Primed Healthy Donors
|
De Felice, Lidia
|
|
2016
|
22 |
10 |
p. 1758-1764
7 p.
|
artikel
|
| 13 |
Hematopoietic Progenitor Cell Mobilization with Ifosfamide, Carboplatin, and Etoposide Chemotherapy versus Plerixafor-Based Strategies in Patients with Hodgkin and Non-Hodgkin Lymphoma
|
Dhakal, Binod
|
|
2016
|
22 |
10 |
p. 1773-1780
8 p.
|
artikel
|
| 14 |
High Variability in the Reported Management of Hepatic Veno-Occlusive Disease in Children after Hematopoietic Stem Cell Transplantation
|
Skeens, Micah A.
|
|
2016
|
22 |
10 |
p. 1823-1828
6 p.
|
artikel
|
| 15 |
Impact of Donor Type on Outcome after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia
|
Solomon, Scott R.
|
|
2016
|
22 |
10 |
p. 1816-1822
7 p.
|
artikel
|
| 16 |
Improved Outcome of Refractory/Relapsed Acute Myeloid Leukemia after Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation with Myeloablative Conditioning and Early Prophylactic Granulocyte Colony-Stimulating Factor–Mobilized Donor Lymphocyte Infusions
|
Jaiswal, Sarita Rani
|
|
2016
|
22 |
10 |
p. 1867-1873
7 p.
|
artikel
|
| 17 |
Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome
|
Alatrash, Gheath
|
|
2016
|
22 |
10 |
p. 1792-1800
9 p.
|
artikel
|
| 18 |
Masthead (Purpose and Scope)
|
|
|
2016
|
22 |
10 |
p. A1-
1 p.
|
artikel
|
| 19 |
Novel Scoring Criteria for the Evaluation of Ocular Graft-versus-Host Disease in a Preclinical Allogeneic Hematopoietic Stem Cell Transplantation Animal Model
|
Perez, Victor L.
|
|
2016
|
22 |
10 |
p. 1765-1772
8 p.
|
artikel
|
| 20 |
Officers and Directors of ASBMT
|
|
|
2016
|
22 |
10 |
p. A4-
1 p.
|
artikel
|
| 21 |
Post-Transplant Outcomes in High-Risk Compared with Non–High-Risk Multiple Myeloma: A CIBMTR Analysis
|
Scott, Emma C.
|
|
2016
|
22 |
10 |
p. 1893-1899
7 p.
|
artikel
|
| 22 |
Preemptive Bone Marrow Transplantation and Event-Free Survival in Fanconi Anemia
|
Khan, Nicholas E.
|
|
2016
|
22 |
10 |
p. 1888-1892
5 p.
|
artikel
|
| 23 |
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies
|
Kennedy, Vanessa E.
|
|
2016
|
22 |
10 |
p. 1801-1807
7 p.
|
artikel
|
| 24 |
Reply to “Early Lung Computed Tomography Scan after Allogeneic Hematopoietic Stem Cell Transplantation”
|
Cornetto, Marie Alice
|
|
2016
|
22 |
10 |
p. 1910-
1 p.
|
artikel
|
| 25 |
Resistant or Sensitive: Time is of the Essence
|
Malek, Ehsan
|
|
2016
|
22 |
10 |
p. 1907-1908
2 p.
|
artikel
|
| 26 |
Resistant or Sensitive: Time Is of the Essence: Response to Malek et al.
|
Hari, Parameswaran
|
|
2016
|
22 |
10 |
p. 1908-
1 p.
|
artikel
|
| 27 |
Restrictive Palivizumab Use Does Not Lead to Increased Morbidity and Mortality in Pediatric Hematopoietic Stem Cell Transplantation Patients
|
Teusink-Cross, Ashley
|
|
2016
|
22 |
10 |
p. 1904-1906
3 p.
|
artikel
|
| 28 |
Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation—Results from a Single-Center Observational Study
|
Grube, Matthias
|
|
2016
|
22 |
10 |
p. 1781-1791
11 p.
|
artikel
|
| 29 |
Severe Cytokine-Release Syndrome after T Cell–Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti–IL-6 Therapy Is Safe and Well Tolerated
|
Abboud, Ramzi
|
|
2016
|
22 |
10 |
p. 1851-1860
10 p.
|
artikel
|
| 30 |
Table of Contents
|
|
|
2016
|
22 |
10 |
p. A8-A16
nvt p.
|
artikel
|
| 31 |
T Cell–Replete HLA Haploidentical Donor Transplantation with Post-Transplant Cyclophosphamide Is an Effective Salvage for Patients Relapsing after an HLA-Matched Related or Matched Unrelated Donor Transplantation
|
Gorgeis, Jessica
|
|
2016
|
22 |
10 |
p. 1861-1866
6 p.
|
artikel
|
| 32 |
The Blood and Marrow Transplant Clinical Trials Network: An Effective Infrastructure for Addressing Important Issues in Hematopoietic Cell Transplantation
|
Steering Committee of the Blood and Marrow Transplant Clinical Trials Network,
|
|
2016
|
22 |
10 |
p. 1747-1757
11 p.
|
artikel
|
| 33 |
The Cost of Mobilization
|
Liu, Hien D.
|
|
2016
|
22 |
10 |
p. 1735-1736
2 p.
|
artikel
|
Tijdschrift beschrijving